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Abstract 
Pituicytomas are rare neoplasms of the sellar region. We report a case of vision loss and a 
junctional scotoma in a 43-year-old woman caused by compression of the optic chiasm by a 
pituitary tumor. The morphological and immunohistochemical characteristics of the tumor 
were consistent with the diagnosis of pituicytoma. The tumor was debulked surgically, and 
the patient’s vision improved. 
 
Introduction 
Pituicytoma is an extremely rare low-grade glioma that presumably arises from 
pituicytes, modified specialized glial cells located in the perivascular zones of the 
neurohypophysis [1]. The rarity of this tumor has contributed to its poor 
characterization and difficulty in diagnosis. To date, only 51 cases of pituicytomas have 
been reported, mostly in pathology, neurosurgery, and radiology journals. To the best 
of our knowledge, this is the first case of pituicytoma to be reported in the ophthalmic 
literature. We report a case of this rare tumor causing decreased vision and a junctional 
scotoma. 
Case Report 
A 43-year-old woman presented with progressive vision loss for 2 months. Her medical and 
ophthalmological histories were unremarkable. When she presented to us, her visual acuity was 
20/15 in the right eye, and she was able to count fingers at 2 feet in the left eye. An afferent pupillary Case Rep Ophthalmol 2012;3:190–195 
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defect was present in the left eye. No strabismus, motility disturbances, or proptosis was observed. 
Automated perimetry showed a superotemporal defect in the right eye and central scotoma in the left 
eye, consistent with a junctional scotoma (fig. 1a, b). Disc pallor was noted bilaterally. There was no 
disc edema. 
Magnetic resonance imaging (MRI) of the brain with gadolinium revealed a solid, homogeneously 
enhancing sellar and suprasellar mass measuring 1.9 × 1.7 × 1.5 cm with compression of the optic 
chiasm (fig. 2a, b). Endocrinological analysis was unremarkable. Transsphenoidal surgery was 
attempted, but could not be achieved due to the highly vascular nature of the tumor. The tumor was 
debulked via a right frontotemporal craniotomy. Postoperative neuro-ophthalmologic examination 
showed that the visual acuity improved to 16/13 in the left eye. There was no afferent papillary defect 
or dyschromatopsia. Repeat visual fields showed a bitemporal hemianopia (fig. 1c). Postoperative 
MRI with gadolinium showed that the lesion had largely been resected, measuring 1.1 × 1.5 × 1.0 cm, 
with improvement in the displacement of the optic chiasm (fig. 2c, d). Postoperatively, the patient 
developed central hypothyroidism and hyperprolactinemia, and was placed on levothyroxine and 
cabergoline. Given the subtotal resection of the tumor, treatment with radiation was discussed but we 
decided on observation. At her most recent follow-up 10 months after surgery, her ophthalmologic 
examination, MRI results, and endocrinological status were stable. 
Histopathological evaluation revealed a moderately cellular tumor composed of elongated cells 
with abundant eosinophilic cytoplasm arranged in a storiform pattern (fig. 3a). There were no mitotic 
figures, necrosis, Rosenthal fibers, or perivascular pseudorosette formation. Immunohistochemical 
stains showed that the tumor was diffusely positive for glial fibrillary acidic protein (GFAP) and 
focally positive for S-100 (fig. 3b, c), but negative for synaptophysin and chromogranin. These 
histological and immunohistochemical features raised the differential diagnosis of oncocytoma, 
granular cell tumor, and pituicytoma. Electron microscopy of tumor cells showed no evidence of 
cytoplasmic accumulations of lysosomes or mitochondria, thus supporting the diagnosis of 
pituicytoma (fig. 3d). 
Discussion 
The clinical presentation of pituicytomas is similar to that of other pituitary tumors, 
with patients typically presenting with visual or endocrinopathic symptoms. On 
neuroimaging, pituicytomas are characterized as a discrete, solid sellar mass that is 
isointense to the surrounding brain on T1-weighted MRI and homogeneously enhancing 
after gadolinium administration [2, 3]. Preoperative diagnosis of pituicytomas is often 
challenging because of the lack of distinctive clinical or radiological features 
differentiating them from other pituitary tumors. Diagnosis of pituicytoma is often 
made only after histopathological analysis. For instance, our patient was initially 
suspected of having a pituitary adenoma. Only after histological and 
immunohistochemical analysis was it determined to be a pituicytoma. 
Pathologic analysis of pituicytomas shows elongated spindle cells arranged in 
interlacing fascicles with little or no nuclear atypia or mitotic activity [4]. 
Immunohistochemistry demonstrates S-100 and GFAP positivity, but negative staining 
for synaptophysin, chromogranin A and B, and neurofilament [5]. The histological and 
immunochemical profiles distinguish pituicytomas from other lesions of the sellar and 
suprasellar region, including pituitary adenoma and meningiomas. Pituitary adenomas 
are synaptophysin reactive, frequently chromogranin positive, and negative for GFAP 
and S-100. In contrast to meningiomas, pituicytomas lack whorls, psammoma bodies, 
and nuclear pseudo-inclusions. Differential diagnosis from other GFAP-positive sellar 
lesions includes pilocytic astrocytomas and diffuse astrocytomas. Pilocytic 
astrocytomas are composed of smaller, more elongated cells with coarse fibrillary Case Rep Ophthalmol 2012;3:190–195 
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processes and often have a myxoid background with scattered eosinophilic granular 
bodies and Rosenthal fibers. Other rare sellar lesions with a similar histological 
appearance are granular cell tumor and oncocytoma characterized on electron 
microscopy by intracytoplasmic accumulations of lysosomes (granular cell tumor) or 
mitochondria (oncocytoma).  
Surgical resection is the mainstay of treatment for pituityctomas. In the largest 
series to date, Brat et al. [4] reported that, among the 6 patient who underwent total 
surgical resection, no recurrences of the tumor occurred. Recurrence after subtotal 
resection is common, with 4 of the 7 cases reported in the literature, among patients 
with a follow-up period of more than 6 months [4, 6–9]. Fractionated radiation therapy 
has been recommended for subtotal resection [9], but there is little data to suggest any 
benefit. 
This report adds to the rare cases of pituicytoma currently in the literature and is 
the first case to be reported in the ophthalmic literature. Our case is also the first to 
report a junctional scotoma caused by pituicytoma. Ophthalmologists should become 
familiar with the clinical, radiological, and histopathological features of this rare 
neoplasm as pituicytomas can cause significant visual symptoms. 
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Fig. 1. a Automated visual field demonstrating a junctional scotoma. b Goldmann visual field testing of 
the left eye showing a central scotoma. c Postoperative visual field showing residual bitemporal 
hemianopia. 
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Fig. 2. Preoperative T1 sagittal (a) and coronal (b) MRI showing compression of the tumor on the 
optic chiasm. Postoperative T1 sagittal (c) and coronal (d) MRI showing debulking of the lesion and 
improvement in compression of the optic chiasm. 
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Fig. 3. Pathology of pituicytoma. a Tumor composed of spindle-shaped cells arranged in interlacing 
fascicle cells. HE stain, ×40. b Positive glial fibrillary acidic protein staining. c Positive 
immunostaining with S-100 protein. d Electron microscopy shows no evidence of cytoplasmic 
accumulations of lysosomes or mitochondria. 
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